Safety Stands Out in Arcellx Cell Therapy’s ASH Data, But Don’t Overlook Manufacturing Advantages

Arcellx’s cell therapy for multiple myeloma has shown no signs of the parkinsonism complication observed in clinical testing of Carvykti, a rival product from partners Johnson & Johnon and Legend Biotech. Arcellx is developing its CAR T-treatment under a partnership with Gilead Sciences. The post Safety Stands Out in Arcellx Cell Therapy’s ASH Data, But…

Some ‘mystery disease’ patients in DRC have malaria, WHO says

UN health body says patients could have more than one disease as unidentified illness continues to cause alarm Ten patients suffering from a mystery disease that has broken out in the Democratic Republic of the Congo have tested positive for malaria, the head of the World Health Organization (WHO) said. However, Dr Tedros Adhanom Ghebreyesus…

France begins military withdrawal from Chad as influence in Africa wanes

Senegal also requests departure of French troops, saying they are ‘not compatible’ with country’s sovereignty France has begun recalling its military assets from its former ally Chad in the latest blow to its dwindling influence across its former colonies in Africa. Two Mirage fighter jets returned to a base in eastern France on Tuesday, said…

Brazil floods are a reminder of the El Niño-climate change compound effect

Unprecedented rainfall – now twice as likely because of global warming – led to devastating flooding across the state of…       Related Stories Cyber insurers look for stability in 2025 Cyber markets look for stability in 2025 Crossing the shifting sands of regulation